Emergence of OXA-48–Like Genes in Carbapenem-Resistant Klebsiella Pneumoniae at a Tertiary Care Hospital in Pakistan
DOI:
https://doi.org/10.51253/pafmj.v75i6.11768Keywords:
Oxacillinase-48-like gene, Carbapenem-resistant Enterobacterales, Carbapenem-resistant Klebsiella pneumoniae, multi-drug resistance, Intensive Care Unit, Polymerase Chain Reaction, Infection prevention, and control.Abstract
Objective: To determine the frequency of the Oxacillinase-48-like gene in Carbapenem-resistant Klebsiella pneumoniae isolates using conventional polymerase chain reaction (PCR).
Study Design: Cross-sectional descriptive study.
Place and Duration of the study: Clinical Pathology Laboratory of Army Medical College, Pak Emirates Military Hospital (PEMH), in collaboration with the Department of Molecular Biology, National University of Medical Sciences, Rawalpindi, Pakistan, from Nov 22 to Jun 23.
Methodology: A total of 266 clinical specimens, including blood, respiratory aspirates, pus, body fluids, and tissue, yielding carbapenem-resistant Klebsiella pneumoniae were analyzed. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disc diffusion method on Mueller-Hinton agar. Detection of the oxacillinase-48-like gene was conducted using conventional PCR. The primers used were forward (5ʹ-GCTTGATCGCCCTCGATT-3ʹ) and reverse (5ʹ-GATTTGCTCCGTGGCCGAAA-3ʹ). PCR products were analyzed using agarose gel electrophoresis. A 281 base pair band was considered positive for the OXA-48-like gene.
Results: Out of 266 carbapenem-resistant isolates, 200 tested positive for the oxacillinase-48-like gene, indicating a frequency of 75.18%. The study findings highlight a high prevalence of the OXA-48-like gene among carbapenem-resistant K. pneumoniae, emphasizing the urgent need for robust infection control strategies and strict implementation of antimicrobial stewardship programs.
Conclusion: The frequency of OXA-48-like gene in carbapenem-resistant Klebsiella pneumoniae was 75.1%. Immediate action is required to prevent its spread among high-risk patients, alongside reinforced antimicrobial stewardship efforts.
Downloads
References
1. Moxley RA. Family Enterobacteriaceae. Vet Microbiol 2022:41-55.
https://doi:10.1002/9781119650836.ch5
2. Shaban S, Allam A, Salah W, Metwally A, Saed Z, Ibrahim M, et al. Brief overview about Enterobacterales antibiotic resistance. Afr J Biol Sci 2024;6(2):4061–4068.
https://doi.org/10.48047/AFJBS.6.2.2024.4061-4068
3. Odari R, Dawadi P. Prevalence of Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates in Nepal. J Trop Med 2022;2022:5309350.
https://doi:10.1155/2022/5309350.
4. Dong N, Yang X, Chan EW, Zhang R, Chen S. Klebsiella species: Taxonomy, hypervirulence and multidrug resistance. EBioMedicine 2022;79:103998.
https://doi:10.1016/j.ebiom.2022.103998
5. Azam MW, Zarrilli R, Khan AU. Updates on the Virulence Factors Produced by Multidrug-Resistant Enterobacterales and Strategies to Control Their Infections. Microorganisms 2023;11(8):1901.
https://doi:10.3390/microorganisms11081901.
6. Pugazhendhi AS, Wei F, Hughes M, Coathup M. Bacterial adhesion, virulence, and biofilm formation. In Musculoskeletal Infection 2022;1(VII):375.
https://doi.org/10.1007/978-3-030-83251-3
7. Joseph L, Merciecca T, Forestier C, Balestrino D, Miquel S. From Klebsiella pneumoniae colonization to dissemination: an overview of studies implementing murine models. Microorganisms 2021;9(6):1282.
https://doi.org/10.3390/microorganisms9061282
8. Mukherjee S, Mitra S, Dutta S, Basu S. Neonatal sepsis: the impact of carbapenem-resistant and hypervirulent Klebsiella pneumoniae. Front Med 2021;8:634349.
https://doi.org/10.3389/fmed.2021.634349
9. Belbase A, Pant ND, Nepal K, Neupane B, Baidhya R, Baidya R, et al. Antibiotic resistance and biofilm production among the strains of Staphylococcus aureus isolated from pus/wound swab samples in a tertiary care hospital in Nepal. Ann Clin Microbiol Antimicrob 2017;16(1):15.
https://doi:10.1186/s12941-017-0194-0.
10. Sethuvel DP, Bakthavatchalam YD, Karthik M, Irulappan M, Shrivastava R, Periasamy H, et al. β-Lactam resistance in ESKAPE pathogens mediated through modifications in penicillin-binding proteins: an overview. Infect Dis Ther 2023; 12(3): 829-841.
https://doi.org/10.1007/s40121-023-00771-8
11. Gondal AJ, Saleem S, Jahan S, Choudhry N, Yasmin N. Novel Carbapenem-Resistant Klebsiella pneumoniae ST147 Coharboring blaNDM-1, blaOXA-48 and Extended-Spectrum β-Lactamases from Pakistan. Infect Drug Resist 2020; 13: 2105-2115.
https://doi:10.2147/IDR.S251532
12. Wang L, Guo L, Ye K, Yang J. Genetic characteristics of OXA-48-producing Enterobacterales from China. J Glob Antimicrob Resist 202; 26: 285-291.
https://doi:10.1016/j.jgar.2021.07.006
13. Onorato L, Monari C, Capuano S, Grimaldi P, Coppola N. Prevalence and Therapeutic Management of Infections by Multi-Drug-Resistant Organisms (MDROs) in Patients with Liver Cirrhosis: A Narrative Review. Antibiotics 2022; 11(2): 232.
https://doi: 10.3390/antibiotics11020232.
14. Rodríguez-Villodres Á, Martín-Gandul C, Peñalva G, Guisado-Gil AB, Crespo-Rivas JC, et al. Prevalence and risk factors for multidrug-resistant organisms’ colonization in long-term care facilities around the world: a review. Antibiotics 2021; 10(6): 680.
https://doi.org/10.3390/antibiotics10060680
15. Isler B, Özer B, Çınar G, Aslan AT, Vatansever C, Falconer C, et al. Characteristics and outcomes of carbapenemase-harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting. Eur J Clin Microbiol Infect Dis 2022; 41(5): 841-847.
https://doi.org/10.1007/s10096-022-04425-4
16. Lan P, Jiang Y, Zhou J, Yu Y. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist 2021; 25: 26-34.
https://doi:10.1016/j.jgar.2021.02.020.
17. Aslan AT, Kırbaş E, Sancak B, Tanrıverdi ES, Otlu B, Gürsoy NC et al. A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting. Int J Antimicrob Agents 2022; 59(4): 106554.
https://doi.org/10.1016/j.ijantimicag.2022.106554
18. Alhazmi W, Al-Jabri A, Al-Zahrani I. The molecular characterization of nosocomial carbapenem-resistant Klebsiella pneumoniae co-Harboring bla NDM and bla OXA-48 in Jeddah. Microbiol Research 2022; 13(4): 753-764.
DOI:10.3390/microbiolres13040054
19. Imtiaz W, Syed Z, Rafaque Z, Andrews SC, Dasti JI. Analysis of Antibiotic Resistance and Virulence Traits (Genetic and Phenotypic) in Klebsiella pneumoniae Clinical Isolates from Pakistan: Identification of Significant Levels of Carbapenem and Colistin Resistance. Infect Drug Resist 2021; 14: 227-236.
https://doi:10.2147/IDR.S293290
20. Thapa S, Adhikari N, Shah AK, Lamichhane I, Dhungel B, Shrestha UT, et al. Detection of NDM-1 and VIM Genes in Carbapenem-Resistant Klebsiella pneumoniae Isolates from a Tertiary Health-Care Center in Kathmandu, Nepal. Chemotherapy 2021; 66(5-6): 199-209.
https://doi:10.1159/000518256
21. Gurung S, Kafle S, Dhungel B, Adhikari N, Thapa Shrestha U, Adhikari B, Banjara MR, Rijal KR, Ghimire P. Detection of OXA-48 Gene in Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae from Urine Samples. Infect Drug Resist 2020; 13: 2311-2321.
https://doi:10.2147/IDR.S259967
22. Pourgholi L, Farhadinia H, Hosseindokht M, Ziaee S, Nosrati R, Nosrati M, Boroumand M. Analysis of carbapenemases genes of carbapenem-resistant Klebsiella pneumoniae isolated from Tehran heart center. Iran J Microbiol 2022; 14(1): 38-46.
https://doi:10.18502/ijm.v14i1.8799
23. Bankar NJ, Ugemuge S, Ambad RS, Hawale DV, Timilsina DR, Ambad R, Timalsina DR. Implementation of antimicrobial stewardship in the healthcare setting. Cureus 2022; 14(7): e26664.
https://doi:10.7759/cureus.26664
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sidra Naveed, Faisal Hanif, Javiad Usman, Rafia Irfan, Warda Furqan, Amna Nasrullah

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





